Profitability
Weight: 15%
F
0
- 5yr Avg ROIC -10.3%
- Operating Margin Trend -219.91 pp/yr
VIR
Vir Biotechnology, Inc.
AlphaQuality composite grade, weighted for high-growth software businesses.
⚠ 3 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a high-growth software business.
Grade overrides the 23.3 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
7
- 5yr Avg ROE -15.9%
- 5yr Share-Count CAGR 3.1%
Growth Quality
Weight: 35%
F
23
- 5yr Revenue CAGR -2.1%
- Revenue-Growth Years (5) 2/5
Cash Generation
Weight: 20%
D+
41
- 5yr FCF Margin -405.2%
- 5yr FCF/NI Conversion 1.48x
Balance Sheet
Weight: 10%
D+
42
- Net Debt / EBITDA 10.00x
- Interest Coverage (EBIT/Int) 30.00x
- Altman Z-Score 2.24
Stability
Weight: 5%
D
36
- Negative-Revenue Years (5) 3/5
- Piotroski F-Score 3
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.2 of 2 gurus held; 1 added; 1 trimmed.
- Holders
- 2
- Avg Δ position
- +70.6%
- New buys
- 0
- Full exits
- 0